Delivery Order SPE2DB22D2206-SPE2DB24FHE69

Award Date 5/14/24
Potential Completion Date 5/15/24
Potential Value $7.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,119.18, is for the supply of "FIRST-MOUTHWASH BLM SUSPENSION 237ML", a medical product. The contract is a Firm Fixed Price arrangement with an ultimate completion date of July 25, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,098.71 firm fixed-price contract is for the delivery of FIRST-MOUTHWASH BLM SUSPENSION 237ML medical supplies. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award, valued at $1,398.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of "FIRST-MOUTHWASH BLM SUSPENSION 119ML" medical supplies, with a completion date of December 19, 2023. This contract is not designated as a set-aside and is a firm fixed-price Delivery Order. AmerisourceBergen holds a significant $999,999,999...
This firm fixed-price delivery order, valued at $3,921.09, was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of "FIRST-MOUTHWASH BLM SUSPENSION 237ML" medical supplies, with an ultimate completion date of January 29, 2024. The award is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $6,696.69, is for "FIRST-MOUTHWASH BLM SUSPENSION 237ML" and has a completion date of July 26, 2024. Amerisourcebergen has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,275.42, is for the provision of "FIRST-MOUTHWASH BLM SUSPENSION 237ML" medical supplies. The contract has a period of performance through July 1, 2024, and utilizes a firm fixed-price pricing structure. Amerisourcebergen holds a significant Indefinite...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,321.20, is for the supply of "FIRST-MOUTHWASH BLM SUSPENSION 119ML" medical products. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of "FIRST-MOUTHWASH BLM SUSPENSION 119ML", with a ceiling value of $1,102.77 and a performance period ending on April 26, 2023. The contract is a Firm Fixed Price (FFP) type and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,349.20 firm fixed-price delivery order is for "FIRST-MOUTHWASH BLM SUSPENSION 119ML", a medical product, with a completion date of May 13, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $6,478.94, is for the provision of a specific pharmaceutical product described as "4564535744 ! FIRST-MOUTHWASH BLM 1S". The contract does not have a set-aside designation and was awarded on a full and open competition basis. Amerisourcebergen...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FHE69
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,285.81, is for the procurement of "FIRST-MOUTHWASH BLM SUSPENSION 237ML" medical supplies. The contract has no set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/16/25, 12:27 PM